戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cells treated with an inhibitor of lysosomal acid lipase.
2 owing cholesteryl esters to be hydrolyzed by acid lipase.
3 uence derived from the propiece of lysosomal acid lipase.
4  Castor bean endosperm contains a well known acid lipase activity that is associated with the oil bod
5 omal/lysosomal pH nor a direct inhibition of acid lipase activity.
6 tudies indicate that administrated lysosomal acid lipase affects the atherogenesis by at least two me
7  that one of the early compartments contains acid lipase (AL), the enzyme required for liberating cho
8 lated with increased expression of lysosomal acid lipase, an M2 macrophage marker.
9 s we have previously described, in lysosomal acid lipase and glucocerebrosidase, and localizes to str
10 eview will focus on the role(s) of lysosomal acid lipase and its use as an enzyme therapy to reduce a
11  LDL-CE hydrolysis is catalyzed by lysosomal acid lipase; (b) neither scavenger receptors nor the LDL
12 NPC1 and NPC2 and several digestive enzymes (acid lipase, beta-glucuronidase, and cathepsins B and D)
13 d cell growth and emphysema during lysosomal acid lipase deficiency are partially caused by peroxisom
14 broblasts from patients with WD (a lysosomal acid lipase deficiency characterized by excessive lipid
15 or desaturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease.
16                                    Lysosomal acid lipase deficiency is a rare, autosomal recessive co
17 herapy in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cir
18  Fabry's disease, Pompe's disease, lysosomal acid lipase deficiency, and five types of mucopolysaccha
19                                    Lysosomal acid lipase deficiency-which can be diagnosed using dry
20 lities in children and adults with lysosomal acid lipase deficiency.
21                                    Increased acid lipase expression and accumulation of free fatty ac
22 ter and triglyceride metabolism in lysosomal acid lipase gene knockout mice (lal-/-) results in sever
23 stem was used to reintroduce human lysosomal acid lipase (hLAL) expression into LAL gene knockout (la
24  or NPC2 protein in NPC disease or lysosomal acid lipase in Wolman disease results in defective cellu
25                                    Lysosomal acid lipase is an essential lipid-metabolizing enzyme th
26                                    Lysosomal acid lipase (LAL) cleaves cholesteryl esters and triglyc
27                                    Lysosomal acid lipase (LAL) cleaves cholesteryl esters and triglyc
28     The underlying mechanisms that lysosomal acid lipase (LAL) deficiency causes infiltration of myel
29                                    Lysosomal acid lipase (LAL) deficiency causes systemic expansion a
30                           Of note, lysosomal acid lipase (LAL) deficiency facilitates melanoma growth
31                                    Lysosomal acid lipase (LAL) has been recently identified as a pote
32                                    Lysosomal acid lipase (LAL) hydrolyzes cholesteryl esters and trig
33                                    Lysosomal acid lipase (LAL) is a key enzyme that cleaves cholester
34                                    Lysosomal acid lipase (LAL) is essential for the clearance of endo
35                                    Lysosomal acid lipase (LAL) is essential for the hydrolysis of cho
36                                    Lysosomal acid lipase (LAL) is essential for the hydrolysis of the
37                                    Lysosomal acid lipase (LAL) is required for the hydrolysis of intr
38                                    Lysosomal acid lipase (LAL) is the critical enzyme for the hydroly
39                                    Lysosomal acid lipase (LAL) is the critical enzyme for the hydroly
40  and their subsequent lipolysis by lysosomal acid lipase (LAL) was important for the engagement of el
41                                    Lysosomal acid lipase (LAL), a key enzyme in the metabolic pathway
42 (CESD), an inherited deficiency of lysosomal acid lipase (LAL), is an underappreciated cause of progr
43 ult from the deficient activity of lysosomal acid lipase (LAL).
44 the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HS
45                      Deficiency of lysosomal acid lipase (LAL; official name Lipa, encoded by Lipa) i
46 rganelles, which in turn indirectly inhibits acid lipase, leading to a subsequent accumulation of cho
47  by mutations in the gene encoding lysosomal acid lipase (LIPA) that result in reduced or absent acti
48 e maintenance of AT; deficiency in lysosomal acid lipase (Lipa), the enzyme required for lysosome lip
49 e worm Caenorhabditis elegans, the lysosomal acid lipase LIPL-4 triggered nuclear translocalization o
50 mice, genomic clones for the mouse lysosomal acid lipase (mLAL) gene were isolated and characterized.
51 on of the lysosomal hydrolase LAL (lysosomal acid lipase) to mobilize FA for FAO and memory T cell de
52  delivery of a lamellar body content marker, acid lipase, to the stratum corneum interstices.
53  with sham-treated mice, the human lysosomal acid lipase-treated mice also have reduced levels of pla
54            Administration of human lysosomal acid lipase via tail vein into mice with atherosclerosis
55 t involves two lysosomal proteins, lysosomal acid lipase, which hydrolyzes C esters, and NPC1 (Nieman

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。